Personalized care Burzynski Clinic focuses on personalized and precision targeted immunotherapy for cancer, presenting an opportunity to position advanced diagnostic partnerships, genetic profiling services, and collaboration on targeted therapies with their clinical team.

Clinical scale With an established footprint in Houston and a staff size of 51-200, there is potential for scalable partnerships in research collaborations, multi-site referral networks, and expanded trial participation to broaden patient access.

Tech enabled Utilizes a modern tech stack and analytics tools; this suggests openness to digital health solutions, data integration, CRM enhancements, and patient engagement platforms to improve outcomes and streamline workflows.

Financial potential Reported revenue in the $10–25 million range indicates a mid-market clinic with room for new service lines, such as companion diagnostic development, value-based care models, or shared-risk arrangements with biotech partners.

Market position Operates in a competitive oncology landscape alongside prominent institutions; identify differentiation through exclusive immunotherapy approaches, access to clinical trials, and streamlined referral pathways to capture a greater share of high-need patients.